Literature DB >> 14523569

Cerebral vasculitis due to Treponema pallidum infection: MRI and MRA findings.

Jochen Gaa, Stefan Weidauer, Matthias Sitzer, Heinrich Lanfermann, Friedhelm E Zanella.   

Abstract

Entities:  

Mesh:

Year:  2003        PMID: 14523569     DOI: 10.1007/s00330-003-2015-4

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


× No keyword cloud information.
  3 in total

1.  Neurosyphilis.

Authors:  R P Simon
Journal:  Arch Neurol       Date:  1985-06

2.  CNS vasculitis in autoimmune disease: MR imaging findings and correlation with angiography.

Authors:  M G Pomper; T J Miller; J H Stone; W C Tidmore; D B Hellmann
Journal:  AJNR Am J Neuroradiol       Date:  1999-01       Impact factor: 3.825

3.  Neurosyphilis in HIV-positive and HIV-negative patients: neuroimaging findings.

Authors:  T C Brightbill; I H Ihmeidan; M J Post; J R Berger; D A Katz
Journal:  AJNR Am J Neuroradiol       Date:  1995-04       Impact factor: 3.825

  3 in total
  5 in total

1.  [Neurosyphilis: important differential diagnosis of herpes simplex encephalitis].

Authors:  B Otto; M Hermans; C Seifried; M Buchkremer; H Lanfermann; M Sitzer
Journal:  Nervenarzt       Date:  2007-08       Impact factor: 1.214

Review 2.  CNS Infections in Immunoincompetent Patients : Neuroradiological and Clinical Features.

Authors:  Stefan Weidauer; Marlies Wagner; Simon Jonas Enkirch; Elke Hattingen
Journal:  Clin Neuroradiol       Date:  2019-09-19       Impact factor: 3.649

3.  Bacterial infections of the central nervous system.

Authors:  Katharina M Busl; Thomas P Bleck
Journal:  Curr Infect Dis Rep       Date:  2013-12       Impact factor: 3.663

Review 4.  Cerebral vasculitis: imaging signs revisited.

Authors:  Wilhelm Küker
Journal:  Neuroradiology       Date:  2007-03-08       Impact factor: 2.995

Review 5.  The role of infectious agents in the pathogenesis of vasculitis.

Authors:  Nicolò Pipitone; Carlo Salvarani
Journal:  Best Pract Res Clin Rheumatol       Date:  2008-10       Impact factor: 4.098

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.